XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Obligations - Additional Information (Detail)
1 Months Ended 9 Months Ended 12 Months Ended
Oct. 15, 2022
d
Sep. 30, 2019
USD ($)
Sep. 30, 2022
USD ($)
d
$ / shares
shares
Dec. 31, 2021
USD ($)
Oct. 26, 2018
USD ($)
Oct. 16, 2018
USD ($)
Subsequent Event [Line Items]            
Debt instrument convertible threshold consecutive trading days | d     5      
Description of debt instrument convertible period     during the five business day period immediately after any five consecutive trading day period      
Principal amount of notes used in conversion rate     $ 1,000      
Debt instrument convertible threshold maximum percentage of product of last reported sale price of common stock     98.00%      
Fair Value of embeded derivative liability     $ 3,080,000 $ 3,080,000    
Level 3 [Member]            
Subsequent Event [Line Items]            
Fair Value of embeded derivative liability     3,080,000 3,080,000    
Deferred Royalty Obligation [Member] | Level 3 [Member]            
Subsequent Event [Line Items]            
Deferred royalty obligation at fair value     129,900,000 129,900,000    
Revenue Interest Financing Agreement [Member]            
Subsequent Event [Line Items]            
Debt issuance costs     $ 1,400,000      
First investment amount   $ 75,000,000.0        
Revenue Interest Financing Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On December 31, 2022 [Member]            
Subsequent Event [Line Items]            
Royalty Payable Percentage on First Investment Amount     65.00%      
Revenue Interest Financing Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On December 31, 2024 [Member]            
Subsequent Event [Line Items]            
Royalty Payable Percentage on First Investment Amount     100.00%      
Revenue Interest Financing Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On September 30, 2026 [Member]            
Subsequent Event [Line Items]            
Royalty Payable Percentage on First Investment Amount     100.00%      
Amended Revenue Interest Agreement [Member]            
Subsequent Event [Line Items]            
Second investment amount     $ 60,000,000.0      
Amended Revenue Interest Agreement [Member] | HealthCare Royalty Partners IV LP [Member] | Royalty Due On December 31, 2024 [Member]            
Subsequent Event [Line Items]            
Royalty Payable Percentage on Second Investment Amount     65.00%      
Revenue Interest Agreement And Amended Revenue Interest Agreement [Member]            
Subsequent Event [Line Items]            
First investment amount     $ 135,000,000.0 135,000,000.0    
Debt Instrument Interest Rate     15.00%      
Revenue Interest Agreement And Amended Revenue Interest Agreement [Member] | HealthCare Royalty Partners IV LP [Member]            
Subsequent Event [Line Items]            
Aggregate Royalties Percentage     185.00%      
Cumulative payments     $ 41,300,000      
Convertible Note Offering [Member]            
Subsequent Event [Line Items]            
Notes converted in to common stock, amount | shares     63.0731      
Notes converted in to common stock, shares     $ 1      
Notes, conversion price per share | $ / shares     $ 15.85      
3% Convertible Senior Notes Due 2025 [Member]            
Subsequent Event [Line Items]            
Aggregate principal amount     $ 172,500,000 172,500,000 $ 22,500,000 $ 150,000,000.0
Debt issuance costs     $ 5,600,000      
Debt discount and issuance costs amortized to interest expense, amortization period     7 years      
Notes, interest rate     3.00%      
Notes, maturity date     Oct. 15, 2025      
Principal amount of notes used in conversion rate     $ 1      
Debt instrument, convertible latest date     Jun. 15, 2025      
Notes conversion price, percentage     130.00%      
Notes instrument, trading days | d     20      
Debt instrument convertible threshold consecutive trading days | d     30      
Estimated fair value of convertible notes     $ 140,300,000 $ 139,200,000    
Expected life of convertible notes     7 years      
Debt Instrument Interest Rate     11.85%      
3% Convertible Senior Notes Due 2025 [Member] | Scenario, Forecast [Member]            
Subsequent Event [Line Items]            
Notes conversion price, percentage 130.00%          
Notes instrument, trading days | d 20          
Debt instrument convertible threshold consecutive trading days | d 30          
Notes, repurchase price 100.00%